A multicenter randomized phase II study of sequential epirubicin/cyclophosphamide followed by docetaxel with or without celecoxib or trastuzumab according to HER2 status, as primary chemotherapy for localized invasive breast cancer patients

Neoadjuvant Treatment With Trastuzumab in HER2-Positive Breast Cancer: Results From the GeparQuattro Study

(2010) Michael Untch et al.   JOURNAL OF CLINICAL ONCOLOGY

Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort

(2010) Luca Gianni et al.   LANCET

Role of combination therapy with aromatase and cyclooxygenase-2 inhibitors in patients with metastatic breast cancer

(2009) C. Falandry et al.   ANNALS OF ONCOLOGY

Preoperative weekly cisplatin, epirubicin, and paclitaxel (PET) improves prognosis in locally advanced breast cancer patients: an update of the Southern Italy Cooperative Oncology Group (SICOG) randomised trial 9908

(2009) G. Frasci et al.   ANNALS OF ONCOLOGY

Hormone receptor status and pathologic response of HER2-positive breast cancer treated with neoadjuvant chemotherapy and trastuzumab

(2008) F. Peintinger et al.   ANNALS OF ONCOLOGY

Cyclooxygenase-2 expression in primary breast cancers predicts dissemination of cancer cells to the bone marrow

(2008) Anthony Lucci et al.   BREAST CANCER RESEARCH AND TREATMENT

Adjuvant/neoadjuvant trastuzumab therapy in women with HER-2/neu-overexpressing breast cancer: A systematic review

(2008) Yolanda Madarnas et al.   CANCER TREATMENT REVIEWS

Treatment of Advanced Hormone-Sensitive Breast Cancer in Postmenopausal Women With Exemestane Alone or in Combination With Celecoxib

(2008) Luc Yves Dirix et al.   JOURNAL OF CLINICAL ONCOLOGY

Preoperative Therapy in Invasive Breast Cancer: Pathologic Assessment and Systemic Therapy Issues in Operable Disease

(2008) Julie R. Gralow et al.   JOURNAL OF CLINICAL ONCOLOGY

Preoperative Chemotherapy: Updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27

(2008) Priya Rastogi et al.   JOURNAL OF CLINICAL ONCOLOGY

Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer

(2008) Cornelia Liedtke et al.   JOURNAL OF CLINICAL ONCOLOGY

Trastuzumab as adjuvant systemic therapy for HER2-positive breast cancer

(2008) Gabriella Mariani et al.   Nature clinical practice. Oncology

Integrating trastuzumab in the neoadjuvant treatment of primary breast cancer: Accumulating evidence of efficacy, synergy and safety

(2007) George Lazaridis et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY